Literature DB >> 12384376

Clinical strain of Pseudomonas aeruginosa carrying a bla(TEM-21) gene located on a chromosomal interrupted TnA type transposon.

Véronique Dubois1, Corinne Arpin, Patrick Noury, Claudine Quentin.   

Abstract

A clinical isolate of Pseudomonas aeruginosa was found to produce a clavulanic acid-inhibited extended-spectrum beta-lactamase with a pI of 6.4. PCR, cloning, and sequencing experiments showed that the corresponding bla(TEM-21) gene was part of a chromosomally located Tn801 transposon disrupted by an IS6100 element and adjacent to an aac(3)-II gene.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12384376      PMCID： PMC128703          DOI： 10.1128/AAC.46.11.3624-3626.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  22 in total

1.  An SHV-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa.

Authors:  T Naas; L Philippon; L Poirel; E Ronco; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Extended-spectrum β-lactamase TEM-4 in Pseudomonas aeruginosa.

Authors:  L Poirel; E Ronco; T Naas; P Nordmann
Journal:  Clin Microbiol Infect       Date:  1999-10       Impact factor: 8.067

3.  A standard numbering scheme for the class A beta-lactamases.

Authors:  R P Ambler; A F Coulson; J M Frère; J M Ghuysen; B Joris; M Forsman; R C Levesque; G Tiraby; S G Waley
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

4.  Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-pectrum beta-lactamase in Pseudomonas aeruginosa in Thailand.

Authors:  Delphine Girlich; Thierry Naas; Amornrut Leelaporn; Laurent Poirel; Michael Fennewald; Patrice Nordmann
Journal:  Clin Infect Dis       Date:  2002-01-23       Impact factor: 9.079

5.  Molecular characterization of integrons in Acinetobacter baumannii: description of a hybrid class 2 integron.

Authors:  M C Ploy; F Denis; P Courvalin; T Lambert
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

6.  Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

Authors:  L Poirel; T Naas; D Nicolas; L Collet; S Bellais; J D Cavallo; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

7.  A TEM-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa.

Authors:  P Mugnier; P Dubrous; I Casin; G Arlet; E Collatz
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

8.  Genes for gentamicin-(3)-N-acetyl-transferases III and IV. II. Nucleotide sequences of three AAC(3)-III genes and evolutionary aspects.

Authors:  R Allmansberger; B Bräu; W Piepersberg
Journal:  Mol Gen Genet       Date:  1985

Review 9.  Trends in beta-lactam resistance among Enterobacteriaceae.

Authors:  P Nordmann
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

10.  The complete DNA sequence and analysis of the large virulence plasmid of Escherichia coli O157:H7.

Authors:  V Burland; Y Shao; N T Perna; G Plunkett; H J Sofia; F R Blattner
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971
View more
  9 in total

Review 1.  Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact.

Authors:  Gerhard F Weldhagen; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

2.  Genetic environments of the rmtA gene in Pseudomonas aeruginosa clinical isolates.

Authors:  Kunikazu Yamane; Yohei Doi; Keiko Yokoyama; Tetsuya Yagi; Hiroshi Kurokawa; Naohiro Shibata; Keigo Shibayama; Haru Kato; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

Review 3.  Current concepts in laboratory testing to guide antimicrobial therapy.

Authors:  Stephen G Jenkins; Audrey N Schuetz
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

Review 4.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

5.  Extended-spectrum-beta-lactamase-producing Enterobacteriaceae strains in various types of private health care centers.

Authors:  Corinne Arpin; Laure Coulange; Véronique Dubois; Catherine André; Isabelle Fischer; Sophie Fourmaux; Frédéric Grobost; Jacqueline Jullin; Brigitte Dutilh; Jean-Francois Couture; Patrick Noury; Isabelle Lagrange; Aline Ducastaing; Henri-Pierre Doermann; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2007-06-25       Impact factor: 5.191

6.  Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.

Authors:  Corinne Arpin; Véronique Dubois; Jeanne Maugein; Jacqueline Jullin; Brigitte Dutilh; Jean-Philippe Brochet; Gilberte Larribet; Isabelle Fischer; Claudine Quentin
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

7.  Prolonged outbreak of infection due to TEM-21-producing strains of Pseudomonas aeruginosa and enterobacteria in a nursing home.

Authors:  Véronique Dubois; Corinne Arpin; Patrick Noury; Catherine Andre; Laure Coulange; Claudine Quentin
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 8.  The accessory genome of Pseudomonas aeruginosa.

Authors:  Vanderlene L Kung; Egon A Ozer; Alan R Hauser
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

9.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers.

Authors:  Corinne Arpin; Véronique Dubois; Laure Coulange; Catherine André; Isabelle Fischer; Patrick Noury; Frédéric Grobost; Jean-Philippe Brochet; Jacqueline Jullin; Brigitte Dutilh; Gilberte Larribet; Isabelle Lagrange; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.